Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.28-$2.45 |
Market Cap | $184.2M |
Shares Short | 43M |
Financials
See moreRevenue (12 Mos) | $31M |
Revenue Growth (YoY) | 3,682.6% |
Gross Profit (12 Mos) | -$52.9M |
Diluted EPS | -$0.63 |
News
See moreYahoo Finance • 24 days ago
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
Yahoo Finance • last month
Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
Yahoo Finance • 2 months ago
Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Yahoo Finance • 2 months ago
Lexicon Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
